Lisata Therapeutics, Inc. Information
Contact top employees from
Lisata Therapeutics, Inc.
Summary
Lisata Therapeutics, Inc. is a public company that has been in the industry for 45 years. The company currently specializes in the Biotechnology, Pharmaceuticals areas. The position of the President & CEO is occupied by David J. Mazzo. Its headquarters is located at Basking Ridge, New Jersey, USA. The number of employees ranges from 1 to 25. The annual revenue of Lisata Therapeutics, Inc. varies between 5.0M and 25M. Total funding of the company - $153.7M. To connect with Lisata Therapeutics, Inc. employee register on SignalHire.
Organization Website | lisata.com |
Social Links |    |
Phone Number | 908-842-0100 |
Industries | |
Headquarters Location | 110 Allen Road, 2nd Flr, Basking Ridge, NJ, 07920 US |
Employees Size | 10-50 employees |
Specialties | biopharmaceuticals |
SIC Code | 2836, 2834 |
DMA Code | New York Metropolitan Area |
Founded | 2006 |
Estimated Annual Revenue | $5.0M - 25M |
Operating Status | Independent Company |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2016 | Privately Held | 25 - 100 | < 1M | $133M | |
| 2004 | Public Company | 100 - 250 | 6.2M | $567.4M | |
| 1997 | Public Company | 25 - 100 | 6.7M | $52.6M | |
| 1995 | - | 200-500 | - | $- |
Estimated Website Traffic
The chart shows a growth in traffic to the lisata.com website. In November, traffic increased to 3086, compared to 2135 in the previous month. The highest traffic in 2025 was recorded in November, reaching 3086 visits.
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at Lisata Therapeutics, Inc. shows a diverse range of experience levels:
3% have been with the company for less than 1 year6% for 1–2 years25% for 3–4 years8% for 5–7 years11% for 8–10 years47% have over 11 years of service at Lisata Therapeutics, Inc.Ex-employees positions
In Company
In New Company
Contact top employees from
Lisata Therapeutics, Inc.
James Nisco
Vice President, Finance and Treasury
William Sietsema
Vice President, Global Regulatory Affairs
Carol Luciano
Senior Executive Assistant to the President & CEO
Kristen Buck MD
Chief Medical Officer and Head of R&D at Lisata Therapeutics
John Menditto
Vice President
Tariq Imam
Senior Vice President, Business Development & Licensing, Operations and General Counsel
James Nisco
Senior Vice President, Finance and Treasury and Chief Accounting Officer
Damian Bonkowski
VP, Controller
Mohammad Azab
Director Board of Directors
Judy Matarese
Director of Clinical Operations
Jacquelyn Briggs
Director Legal
Peter Traber
Member Board of Directors
omar snoussi
Research & Process development Associate
Aaron Kneppar
Director, Network Engineering & Cybersecurity
Nicole Fulvio
Executive Administrative Assistant, Clinical Safety Associate
Robin Smith
Executive Chairman
Greg Berkin
Chief Information Officer and Chief Information Security Officer and Data Protection Officer
Amy Jackson Ayala
Associate Director, Regulatory Reporting & Governance, Asst Corporate Secretary
Carlos Ramos
Sr. Systems Engineer
Neil Losordo
Finance Intern
Maggie Naughton
Senior Clinical Site Manager
Steve Sizer
Executive Administrative Assistant
Lauren Lulic
Associate Director, Corporate Marketing and Communications
Shannon Naughton
Associate Director Clinical Operations
Tammie McLeod
Sr. Clinical Trial Assoc.
Katherine Stiles
Clinical Research Associate
Bharat Bhadra
Lead Programmer
Similar Companies
FAQ
Lisata Therapeutics, Inc. operates in the Biotech industries. More details can be found on the official website: lisata.com.
The headquarters of Lisata Therapeutics, Inc. are located in Basking Ridge, United States.
The current CEO of Lisata Therapeutics, Inc. is David J. Mazzo
You can contact Lisata Therapeutics, Inc. by phone at 908-842-0100.
Lisata Therapeutics, Inc. currently employs 10-50 people.
Lisata Therapeutics, Inc.'s revenue is approximately 16M.
Well-known competitors of Lisata Therapeutics, Inc. include Surrozen, Mesoblast Limited, Alliqua BioMedical, Inc. and Sangamo Therapeutics, Inc..
